Is Pfizer moving part of its production from Belgium to Romania?

US pharmaceutical company Pfizer has announced its intention to move some of its production facilities from Belgium to Romania, where labour costs are lower, according to Italian newspaper Il fato Cotidiano

Pfizer seen in Cambridge, Massachusetts, on Oct. 5, 2018. (Ruby Wallau for STAT)

The paper says that 38 of its 238 employees will lose their jobs because of this.

“This is another slap in the face to the millions of EU citizens who seek social justice rather than business savvy,” said Daniela Rondinelli, a member of the European Parliament and a member of the Five Star Movement.

Belgian unions have also reacted to the US company’s decision to shift production to a lower workforce and thereby increase profits.

“This is an unprecedented disgrace. Thanks to European funds for the invention of an antiviral vaccine, Pfizer made 3.3 billion euros last year, and it announces profits of around 15 billion this year. In recent months, Pfizer employees have been working double shifts to produce the necessary antivirals. After all, layoffs are a blow to the stomachs of workers”, –  said Bart Decoullier, general secretary of the Belgian trade union ACV.

The US company Pfizer has developed the antivaccine together with the German company Biontek.

The rapid development of the drug was made possible by a major investment in research, some 2.5 billion euros, and they received 400 million euros from the EU alone in the early stages of research.

Comments:

comments powered by HyperComments